SYSTEMATIC REVIEW article
Front. Pharmacol.
Sec. Ethnopharmacology
Volume 16 - 2025 | doi: 10.3389/fphar.2025.1578371
This article is part of the Research TopicPrevention and Treatment of Metabolic Diseases Using Bioactive Metabolites of Herbal Medicines Also Used as FoodsView all 14 articles
Metabolic Dysfunction-Associated Fatty Liver in type 2 diabetes mellitus patient: Can a systematic review of and Meta-Analysis of commonly used TCM-preparation shed light on their efficacy?
Provisionally accepted- 1College of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun, China
- 2Institute of Metabolic Diseases, Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China
- 3College of Traditional Chinese Medicine, Ningxia Medical University, Yinchuan, Ningxia Hui Region, China
- 4Department of Endocrinology, The First Affiliated Hospital of Changchun University of Chinese Medicine, Changchun, China
- 5Gastroenterology department , Yanji/Yanbian Traditional Chinese Medicine Hospital, Yanji, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background:Type 2 diabetes mellitus (T2DM) and Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) are mutually causal, which can jointly promote the development of the disease. As an important means to evaluate the steatosis of MAFLD, Controlled Attenuation Parameter (CAP) can also evaluate the metabolism related fat parameters. Whether Traditional Chinese Medicine preparation (TCM-preparation) can improve CAP has not been reported yet, so the purpose of this meta-analysis is to evaluate the effect of TCM-preparation on CAP in T2DM patients with MAFLD.Methods: In this meta-analysis, eight databases were searched from the establishment of the database to April 23, 2025, to obtain clinical randomized controlled trials (RCTs) of TCM-preparation or TCM-preparation combined with Standard Biomedical Treatment (SBT) in the treatment of T2DM complicated with MAFLD. After screening the literature and extracting the data, Meta-analysis was conducted using RevMan5.4 software, with results presented in the form of a forest plot. This study was registered with PROSPERO (CRD42024569613).Results:A total of 599 papers were retrieved, and the papers were screened according to the nadir and ranking criteria, and finally 8 trials (648 participants) were included in this study. Meta-analysis showed that TCM-preparation significantly reduced CAP values in patients with T2DM combined with MAFLD compared with TCM-preparation (MD = -10.26, CI [-15.33, -5.18], P < 0.00001).Conclusion: TCM-preparation can reduce the CAP value of T2DM combined with MAFLD and can have a good therapeutic effect on glucose-lipid metabolism level and liver function, indicating that TCM-preparation can reduce the deposition of hepatic fat, restore the function of hepatocytes, and have a positive effect on T2DM combined with MAFLD; however, due to the heterogeneity of the included literature, it needs to be further validation by high-quality trials.
Keywords: TCM-preparation, Metabolic Dysfunction-Associated Fatty Liver Disease(MAFLD), Type 2 diabetes mellitus(T2DM), Meta-analysis, Systematic review
Received: 17 Feb 2025; Accepted: 29 Jul 2025.
Copyright: © 2025 Cao, Bao, Cao, Fan, Wang, Yu, Wang, Deng, Shi, Shen, Li and Mi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Qingwei Li, Institute of Metabolic Diseases, Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053, China
Jia Mi, Department of Endocrinology, The First Affiliated Hospital of Changchun University of Chinese Medicine, Changchun, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.